project id: TCGA-HNSC; case submitter id: TCGA-UF-A71E; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.69; rna integrity number: 8.6; age at index: 63; days to birth: -23071; days to death: 1504; ethnicity: not reported; gender: male; race: white; vital status: Dead; year of birth: 1947; age at diagnosis: 23071; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IVA; ajcc clinical t: T4; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IVA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1278.0; icd 10 code: C04.9; last known disease status: not reported; morphology: 8083/3; primary diagnosis: Basaloid squamous cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Floor of mouth, NOS; synchronous malignancy: No; tissue or organ of origin: Floor of mouth, NOS; tumor grade: Not Reported; year of diagnosis: 2010; alcohol history: Yes; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 190.0; portion submitter id: TCGA-UF-A71E-01A-31; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 75.0;